Ira Wollner

4.4k total citations · 1 hit paper
31 papers, 3.4k citations indexed

About

Ira Wollner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Ira Wollner has authored 31 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Hepatology. Recurrent topics in Ira Wollner's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and CAR-T cell therapy research (5 papers). Ira Wollner is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and CAR-T cell therapy research (5 papers). Ira Wollner collaborates with scholars based in United States. Ira Wollner's co-authors include Drew M. Pardoll, Julie R. Brahmer, Suzanne L. Topalian, Charles G. Drake, William H. Sharfman, Lieping Chen, Alice Pons, Janis M. Taube, Robert A. Anders and John D. Powderly and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Ira Wollner

30 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

2010 2.3k citations Julie R. Brahmer, Charles G. Drake et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ira Wollner United States	15	2.6k	1.4k	739	486	307	31	3.4k
Tara C. Gangadhar United States	32	3.0k 1.1×	1.8k 1.3×	565 0.8×	1.0k 2.1×	199 0.6×	75	4.0k
Rachel E. Sanborn United States	25	2.8k 1.1×	1.1k 0.8×	1.3k 1.7×	751 1.5×	513 1.7×	154	3.7k
Abraham Chachoua United States	24	2.7k 1.0×	983 0.7×	1.6k 2.1×	764 1.6×	312 1.0×	75	3.9k
Cornelis J. A. Punt Netherlands	25	1.3k 0.5×	1.0k 0.8×	312 0.4×	622 1.3×	213 0.7×	70	2.4k
Timothy L. Frankel United States	28	1.5k 0.6×	733 0.5×	557 0.8×	663 1.4×	543 1.8×	81	2.6k
April K.S. Salama United States	33	2.8k 1.1×	1.2k 0.9×	792 1.1×	1.3k 2.6×	229 0.7×	131	4.0k
Rathi N. Pillai United States	29	3.0k 1.2×	1.5k 1.1×	1.5k 2.0×	766 1.6×	577 1.9×	87	4.4k
Steven J. Lemery United States	26	1.8k 0.7×	613 0.5×	852 1.2×	545 1.1×	482 1.6×	65	3.3k
Jimmy J. Hwang United States	32	2.5k 1.0×	833 0.6×	814 1.1×	940 1.9×	780 2.5×	159	4.2k
Carl Plager United States	32	2.4k 0.9×	833 0.6×	1.2k 1.6×	1.1k 2.4×	339 1.1×	71	3.7k

Countries citing papers authored by Ira Wollner

Since Specialization

Citations

This map shows the geographic impact of Ira Wollner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ira Wollner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ira Wollner more than expected).

Fields of papers citing papers by Ira Wollner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ira Wollner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ira Wollner. The network helps show where Ira Wollner may publish in the future.

Co-authorship network of co-authors of Ira Wollner

This figure shows the co-authorship network connecting the top 25 collaborators of Ira Wollner. A scholar is included among the top collaborators of Ira Wollner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ira Wollner. Ira Wollner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khan, Gazala, et al.. (2024). Treatment of unresectable and resectable stage IV colorectal cancer.. PubMed. 22(9). 455–463.

Brahmer, Julie R., Charles G. Drake, Ira Wollner, et al.. (2023). Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates. Journal of Clinical Oncology. 41(4). 715–723. 31 indexed citations

Veenstra, Jesse, et al.. (2020). Why is My Skin Turning Black? A Rare Side Effect of Capecitabine. SKIN The Journal of Cutaneous Medicine. 4(3). 275–278. 1 indexed citations

Eggly, Susan, Lauren M. Hamel, Tanina Foster, et al.. (2016). Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists. Patient Education and Counseling. 100(5). 818–826. 60 indexed citations

Lipson, Evan J., William H. Sharfman, Charles G. Drake, et al.. (2012). Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody. Clinical Cancer Research. 19(2). 462–468. 425 indexed citations

Muñoz, Javier, et al.. (2011). Post-embolization syndrome: Outcomes regarding the type of embolization.. Journal of Clinical Oncology. 29(15_suppl). e14582–e14582. 5 indexed citations

Velanovich, Vic & Ira Wollner. (2011). Quality of life and performance status in patients with pancreatic and periampullary tumors. International Journal of Clinical Oncology. 16(4). 401–407. 12 indexed citations

Muñoz-Langa, José, et al.. (2011). Hypertension as a clinical marker of response to bevacizumab across malignancies.. Journal of Clinical Oncology. 29(15_suppl). e16601–e16601. 2 indexed citations

Brahmer, Julie R., Charles G. Drake, Ira Wollner, et al.. (2010). Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates. Journal of Clinical Oncology. 28(19). 3167–3175. 2331 indexed citations breakdown →

10.

Kaseb, Ahmed O., et al.. (2009). Vascular endothelial growth factor in the management of hepatocellular carcinoma. Cancer. 115(21). 4895–4906. 102 indexed citations

11.

Brell, Joanna M., Smitha Krishnamurthi, Milind Javle, et al.. (2008). A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma. Cancer Chemotherapy and Pharmacology. 63(5). 851–857. 11 indexed citations

12.

Wollner, Ira, et al.. (2002). Squamous cell carcinoma of the buccal mucosa with metastases to the pericardial cavity, lung and thyroid. Oral Oncology. 38(1). 114–116. 25 indexed citations

13.

Velanovich, Vic, Ira Wollner, & Munther Ajlouni. (2000). Staging laparoscopy promotes increased utilization of postoperative therapy for unresectable intra-abdominal malignancies. Journal of Gastrointestinal Surgery. 4(5). 542–546. 28 indexed citations

14.

Andrews, James C., et al.. (1989). Floxuridine-Associated Sclerosing Cholangitis A Dog Model. Investigative Radiology. 24(1). 47–51. 3 indexed citations

15.

Wollner, Ira, James C. Andrews, Suzette C. Walker-Andrews, et al.. (1989). Combination Chemo-radiation Therapy for Jaundice Due to Focal Malignant Obstruction of the Major Bile Ducts. PubMed. 5(2). 81–91. 3 indexed citations

16.

Lawrence, Theodore S., Suzette C. Walker-Andrews, James C. Andrews, et al.. (1989). Treatment of cancers of the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine. International Journal of Radiation Oncology*Biology*Physics. 17. 219–219. 2 indexed citations

17.

Stetson, P L, Jonathan Maybaum, John G. Wagner, et al.. (1988). Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.. PubMed. 48(23). 6900–5. 10 indexed citations

18.

Wollner, Ira, Diane M. Prieskorn, Clarence E. Chrisp, et al.. (1988). Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer. 61(7). 1336–1344. 74 indexed citations

19.

Wollner, Ira, et al.. (1986). Phase II Study of Hepatic Arterial Degradable Starch Microspheres and Mitomycin. PubMed. 3(4). 279–284. 15 indexed citations

20.

Wagner, John G., John W. Gyves, Philip L. Stetson, et al.. (1986). Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.. PubMed. 46(3). 1499–506. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact